-
-
-
-
-
-
-
C4 Therapeutics Inc. (CCCC) files $400M mixed shelf
-
-
-
-
-
-
-
C4 Therapeutics, Inc. (CCCC) Tops Q2 EPS by 3c
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC)
-
-
-
-
-
-
-
C4 Therapeutics, Inc. (CCCC) Reports In-Line Q2 EPS
-
416,804 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

